Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results.

Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results. Abstract Text:

Keiko Nakayama,Yoichi Kuwabara,Masao Daimon,Satoshi Shindo,Miwa Fujita,Hiroya Narumi,Hiroshi Mizuma,Issei Komuro,Keiko Nakayama,Yoichi Kuwabara,Masao Daimon,Satoshi Shindo,Miwa Fujita,Hiroya Narumi,Hiroshi Mizuma,Issei Komuro,

Antihypertensive therapy has been well established to reduce hypertension-related morbidity and mortality, but the optimal therapy for Japanese patients remains unknown. The Valsartan Amlodipine Randomized Trial (VART), a prospective randomized open-label trial, was designed to determine whether treatment with an angiotensin II type 1 receptor blocker (valsartan) or a calcium channel blocker (amlodipine) lowers cardiovascular disease events in essential hypertensives in Japan. Registration, randomization and data entry were performed over the Internet. The minimization method (to control for age, gender, blood pressure level and history) was used at random assignment to ensure that the background factors were equivalent between the groups at baseline. After the registration, patients were followed-up for cardiovascular events (primary endpoints), echocardiography, (123)I-metaiodobenzylguanidine (MIBG) imaging, laboratory tests and blood pressure for 3 years. Currently, 797 patients have been enrolled and assigned to two groups: a valsartan (n=399) and an amlodipine (n=398) group. At baseline, controlled factors (age, gender, blood pressure level, and left ventricular hypertrophy) and the proportions of patients with diabetes and hyperlipidemia were equally allocated. At 12 months, both drugs evenly and significantly lowered blood pressure to the target level (valsartan: 133/79 mmHg; amlodipine: 132/79 mmHg). In conclusion, by combining the data on cardiovascular events with the results of echocardiographic, radionuclide imaging, and blood/urine studies, the VART study will provide mechanistic insights into the clinical outcomes and treatment effects of the trial. (Hypertens Res 2008; 31: 21-28).

Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results. Publishing Authors By Initials

K Nakayama,Y Kuwabara,M Daimon,S Shindo,M Fujita,H Narumi,H Mizuma,I Komuro,K Nakayama,Y Kuwabara,M Daimon,S Shindo,M Fujita,H Narumi,H Mizuma,I Komuro,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Hypertension research : official journal of the Ja

VOLUME: 31

Page Numbers: 21-8

Journal Abbreviation: Hypertens. Res.

ISSN: 0916-9636

DAY: 24

MONTH: Jan

YEAR: 2008

Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9307690

Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results.

AFFILIATION: Department of Cardiovascular Science and Medicine, Chiba University Graduate School of Medicine.

Country: Japan

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Hypertens Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Valsartan Amlodipine Randomized Trial VART: Design, Methods, and Preliminary Results Related Publications

• A crucial role of a high mobility group protein HMGA2 in cardiogenesis.
• Angiosarcoma in the right atria demonstrated by fusion images of multislice computed tomography and positron emission tomography using F-18 Fluoro-Deoxyglucose.
• Angiotensin II Type 1a Receptor Signals are Involved in the Progression of Heart Failure in MLP-Deficient Mice.
• Cerebellar granule cell migration and the effects of alcohol.
• Coarctation of the descending aorta, patent ductus arteriosus, deficiency of right superior vena cava, and persistent left superior vena cava in a five-month infant demonstrated by multislice computed tomography.
• Conformational switch of angiotensin II type 1 receptor underlying mechanical stress-induced activation.
• Damage to polymer of undelivered sirolimus-eluting stents.
• Do not forget vasospastic angina in patients with chest pain at rest and no significant coronary stenosis with multidetector computed tomography.
• Double outlet right ventricle demonstrated by multislice computed tomography.
• Feasibility and safety of granulocyte colony-stimulating factor treatment in patients with acute myocardial infarction.
• Focal fibrosis in the left ventricle of subjects with cardiac amyloidosis evaluated by multislice computed tomography.
• G-CSF therapy for acute myocardial infarction.
• How does alcohol impair neuronal migration?
• Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.
• Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes.
• Impact of drug-eluting stents on clinical and angiographic outcomes in dialysis patients.
• Incidence of premature discontinuation of antiplatelet therapy after sirolimus-eluting stent implantation.
• Interstitial cells of Cajal associated with the submucosal plexus of the Guinea-pig stomach.
• Late stent thrombosis in patients receiving ticlopidine and aspirin after sirolimus-eluting stent implantation.
• Multivessel coronary artery spasm refractory to intensive medical treatment.
• Reduced nitric oxide causes age-associated impairment of circadian rhythmicity.
• Role of heat shock transcriptional factor 1 and heat shock proteins in cardiac hypertrophy.
• Role of telomeres in vascular senescence.
• Takayasu arteritis evaluated by multi-slice computed tomography in an old man.
• The new acyl-CoA cholesterol acyltransferase inhibitor SMP-797 does not interact with statins via OATP1B1 in human cryopreserved hepatocytes and oocytes expressing systems.
• Transferring images via the wireless messaging network using camera phones shortens the time required to diagnose acute coronary syndrome.
• Valsartan Amlodipine Randomized Trial (VART): Design, Methods, and Preliminary Results.
• [ON DIFFUSION OF LINCOMYCIN INTO EYE TISSUES, WITH SPECIAL REFERENCE TO A SENSITIVITY TEST FOR PATHOGENIC STAPHYLOCOCCI.]
• [P53 and its role in the development of heart failure]
• [Thymoma extending into the right atrium]